Patient registries: EMA officials highlight opportunities in orphan drug development

Regulatory NewsRegulatory NewsBiologicsBiotechnologyClinical TrialsCombination ProductsDiagnosticsEuropeMedical DevicesOtherPharmaceuticalsPreclinical studyProduct LifecycleRegulatory Intelligence/PolicyResearch, Design and Development